Enhanced stimulation for gastroparesis relief
Part of Digestive system clinical trials.
This trial tests a new way to program an implanted device (Enterra®) to better treat severe nausea and vomiting caused by gastroparesis. If you have frequent nausea and vomiting despite other treatments, this study might help find a better setting for your device.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old and have had gastroparesis for at least one year (either from diabetes or unknown cause).
- A recent stomach emptying test (Eggbeaters™) shows food stays in your stomach too long.
- You have severe nausea (score 2.5 or higher on a scale) and vomit 5 or more times each week.
- You have had a normal endoscopy (camera test) in the last year.
- You agree not to use cannabis more than 3 days per week or more than 3 grams total weekly.
- You have not had surgery or procedures on your stomach or pylorus (pyloroplasty, pyloromyotomy, G-POEM).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a special single-patient program for a person with gastroparesis who has moderate to severe nausea. It provides access to an investigational drug called tradipitant, which may help relieve nausea, when no other clinical trials are available.
This study tests a new way to program the Enterra stomach pacemaker so it cycles at night, aiming to improve gastroparesis symptoms. It's for people who already have the device and have stable symptoms.
This study tests whether a device that sends gentle electrical pulses to the stomach, already implanted for at least 8 weeks, can reduce daily stomach pain in people with gastroparesis. It may help if you have had chronic stomach pain for more than 2 months.
This study tests whether placing a small, implanted device that sends gentle electrical pulses to the stomach can improve symptoms of severe gastroparesis—a condition where the stomach empties too slowly. It's for people whose symptoms haven't been controlled with other treatments and are significantly affecting their daily life.
This study follows people with drug-refractory gastroparesis (stomach paralysis symptoms that don’t improve with usual medicines) to better understand how symptoms and nutrition change over time. Your information may help researchers understand patterns that could improve care.
This trial tests a procedure called G-POEM that may help with severe gastroparesis, where the stomach is slow to empty. It aims to improve blood sugar control and stomach symptoms for people with diabetes.
Hear when a new Gastroparesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.